Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Catalyst Pharmaceuticals (CPRX) Inventory Average: 2019-2025

Historic Inventory Average for Catalyst Pharmaceuticals (CPRX) over the last 7 years, with Sep 2025 value amounting to $23.3 million.

  • Catalyst Pharmaceuticals' Inventory Average rose 22.74% to $23.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.3 million, marking a year-over-year increase of 22.74%. This contributed to the annual value of $17.6 million for FY2024, which is 56.73% up from last year.
  • According to the latest figures from Q3 2025, Catalyst Pharmaceuticals' Inventory Average is $23.3 million, which was up 21.47% from $19.2 million recorded in Q2 2025.
  • Catalyst Pharmaceuticals' 5-year Inventory Average high stood at $23.3 million for Q3 2025, and its period low was $4.5 million during Q1 2021.
  • For the 3-year period, Catalyst Pharmaceuticals' Inventory Average averaged around $16.3 million, with its median value being $19.0 million (2024).
  • As far as peak fluctuations go, Catalyst Pharmaceuticals' Inventory Average soared by 184.38% in 2021, and later decreased by 5.96% in 2022.
  • Quarterly analysis of 5 years shows Catalyst Pharmaceuticals' Inventory Average stood at $7.4 million in 2021, then fell by 5.96% to $7.0 million in 2022, then surged by 77.08% to $12.3 million in 2023, then surged by 60.29% to $19.8 million in 2024, then grew by 22.74% to $23.3 million in 2025.
  • Its Inventory Average stands at $23.3 million for Q3 2025, versus $19.2 million for Q2 2025 and $19.7 million for Q1 2025.